サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563903

心臓血管超音波システムの世界市場

Cardiovascular Ultrasound Systems
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
心臓血管超音波システムの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

心臓血管超音波システムの世界市場は2030年までに23億米ドルに達する見込み

2023年に16億米ドルと推定される心臓血管超音波システムの世界市場は、2023年から2030年にかけてCAGR 5.2%で成長し、2030年には23億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである2D技術は、CAGR 5.0%を記録し、分析期間終了までに11億米ドルに達すると予測されます。3D&4Dテクノロジー分野の成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は4億2,280万米ドル、中国はCAGR4.9%で成長予測

米国の心臓血管超音波システム市場は、2023年に4億2,280万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを4.9%として、2030年までに3億5,790万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.6%と4.3%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界の心臓血管超音波システム市場- 主要動向と促進要因のまとめ

心臓血管超音波システムは心臓診断にどのような革命をもたらしているのか？

心臓血管超音波システムは、一般的に心エコーシステムとして知られ、高周波音波を使用して心臓とその周辺構造の詳細な画像を作成する非侵襲的診断ツールです。これらのシステムは、心臓弁障害、心不全、先天性心疾患、冠動脈疾患など、さまざまな心血管系疾患の診断、モニタリング、管理に不可欠です。心臓血管超音波システムは、心臓の部屋、弁、血流をリアルタイムで画像化することにより、カテーテル検査や手術などの侵襲的な処置を必要とすることなく、医師が心臓の機能を評価することを可能にします。心臓の健康状態を迅速に評価し、リアルタイムで異常を検出する能力により、心臓血管超音波検査は、特に外来、救急、周術期の環境において、現代の心臓病学の要となっています。これらのシステムは放射線の代わりに音波を使用するため、患者へのリスクがなく、妊婦や小児を含む幅広い集団に適しています。心臓専門医は、経胸壁心エコー図（TTE）、経食道心エコー図（TEE）、負荷心エコー図など、さまざまな種類の心エコー図を実施するためにこれらのシステムを利用しており、それぞれが心臓機能のさまざまな側面について独自の洞察を提供しています。心臓血管超音波システムの非侵襲的な性質と診断精度は、心臓病の早期診断と長期的管理の両面で不可欠なツールとなっています。

技術の進歩は心臓血管超音波システムをどのように改善したか？

技術の進歩は心臓血管超音波システムを劇的に変化させ、診断能力、携帯性、使いやすさを向上させました。最も重要な進歩のひとつは、3次元（3D）および4次元（4D）心エコー検査のイントロダクションです。これらの技術は、心臓の構造と機能をより包括的にとらえることができるため、臨床医は心臓弁をよりよく可視化し、異常を検出し、弁の置換や修復のような複雑な介入を計画することができます。さらに、3Dや4D画像は、先天性心疾患や心臓の構造的な問題を手術開始前に正確に画像化することで、手術結果を改善することができます。このレベルの詳細な画像は、従来の2次元心エコーでは得られなかったものであり、診断や治療計画の精度を著しく向上させています。もう一つの技術的な飛躍は、ポータブルでハンドヘルドの心臓血管超音波システムの台頭です。これらのコンパクトな装置により、臨床医は大型の据置型装置を必要とせず、患者のベッドサイドや救急部、あるいは遠隔地でも心エコー図を実施することができます。この可搬性により、特に、従来の心エコー装置が利用できないような、十分なサービスが行き届いていない地域や田舎では、重要な診断ツールへのアクセスが向上します。さらに、最新の超音波診断装置の多くには、画像の解釈や解析を支援する高度なAIや機械学習アルゴリズムが搭載されています。これらのAIを搭載したシステムは、心臓の異常を自動的に検出して定量化することができるため、手作業による解析に要する時間を大幅に短縮し、診断の一貫性を向上させることができます。クラウドベースの接続とデータ共有機能により、最新の超音波システムの機能はさらに強化され、医療従事者と遠隔地の専門医とのリアルタイムの連携が可能になり、タイムリーで正確な患者ケアが保証されます。

心臓血管超音波システムの新たな動向とは？

心臓血管超音波システムが進化を続けている背景には、医療画像技術の進歩やヘルスケアニーズの変化を反映した、いくつかの新たな動向があります。大きな動向の一つは、心臓病学におけるポイントオブケア超音波検査（POCUS）の普及です。POCUSシステムとは、ヘルスケアプロバイダーが患者のベッドサイドや外来で心エコー検査を実施できる小型のポータブル機器です。この動向は、特に迅速な診断が重要な救急医療現場において、心血管系画像検査へのアクセスを増加させています。また、プライマリ・ケアや一般診療にも超音波の利用が拡大し、専門の画像診断センターを必要とせずに心血管系の問題を早期に発見できるようになっています。人工知能（AI）と機械学習の心臓血管超音波システムへの統合も重要な動向です。AIは画像収集、解析、報告の様々な側面を自動化するために使用され、オペレーターの専門知識への依存を減らし、ヒューマンエラーを最小限に抑えます。例えば、AIアルゴリズムは、心臓の異常の検出、駆出率の測定、心臓弁の動きの追跡などを、より正確かつ迅速に支援することができます。このようなAI主導の機能は、診断手順の標準化に役立ち、経験の浅いオペレーターでも高品質の結果を出せるようにします。もう1つの重要な動向は、造影エコー検査の利用が増加していることです。造影エコー検査は、特に画質が十分でない患者において、心臓構造の可視性を向上させる。血液中に注入される造影剤は、超音波検査で得られる画像の鮮明度を高め、虚血性心疾患や心筋梗塞などの状態をより正確に評価することを可能にします。最後に、相互運用性の動向により、心臓血管超音波システムは、より広範な病院情報システム（HIS）や循環器情報システム（CVIS）との統合が容易になり、異なる部門間の患者データのシームレスな流れを作り出し、医療連携を向上させています。

心臓血管超音波システム市場拡大の要因は？

心臓血管超音波システム市場の成長は、主にテクノロジーの進歩、ヘルスケア需要の高まり、医療提供者のニーズの進化に関連するいくつかの要因によって牽引されています。最も大きな原動力の一つは、心不全、冠動脈疾患、高血圧などの心血管疾患の世界の有病率の増加です。これらの疾患が増加し続ける中、心臓血管超音波システムのような非侵襲的で正確、かつ費用対効果の高い診断ツールの需要が急増しています。ヘルスケアプロバイダーは、心臓疾患の早期診断、疾患進行のモニタリング、治療効果の評価など、患者の予後改善に貢献するこれらのシステムへの依存度を高めています。もう1つの大きな成長要因は、よりポータブルなポイントオブケア超音波装置へのシフトであり、これにより従来の病院環境以外にも心エコー検査の用途が広がっています。ポータブル機器により、ヘルスケアプロバイダーは、特に緊急時や遠隔地の患者に画像診断を提供することができ、タイムリーな治療を保証し、高価で侵襲的な処置の必要性を減らすことができます。3Dおよび4Dイメージング、AI統合、クラウド接続などの技術的進歩も、これらのシステムの機能性、精度、使いやすさを向上させることで市場の成長を促進しています。さらに、ヘルスケアにおけるAIの採用の高まりは、これらのシステムの診断能力を強化し、より迅速で一貫性のある画像解釈を可能にしています。バリュー・ベース・ケアの動向は、コストを抑制しながらアウトカムを改善することに重点を置いており、CTやMRIのような他の画像診断モダリティに代わる、費用対効果の高い非侵襲的な選択肢を提供するため、心臓血管超音波システムの採用をさらに後押ししています。最後に、特に発展途上地域におけるヘルスケアインフラへの投資の拡大が、高度な超音波技術へのアクセスを拡大し、市場の成長をさらに加速させています。世界中のヘルスケア・システムが心血管疾患の早期診断と管理の向上に努めているため、心臓血管超音波システムの需要は今後も高まり続けると予想されます。

調査対象企業の例（注目の13社）

  • Chison Medical Imaging Co., Ltd.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Mindray Medical International Ltd.
  • Philips Healthcare
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10905

Global Cardiovascular Ultrasound Systems Market to Reach US$2.3 Billion by 2030

The global market for Cardiovascular Ultrasound Systems estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. 2D Technology, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the 3D & 4D Technology segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$422.8 Million While China is Forecast to Grow at 4.9% CAGR

The Cardiovascular Ultrasound Systems market in the U.S. is estimated at US$422.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$357.9 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Cardiovascular Ultrasound Systems Market - Key Trends and Drivers Summarized

How Are Cardiovascular Ultrasound Systems Revolutionizing Heart Diagnostics?

Cardiovascular ultrasound systems, commonly known as echocardiography systems, are non-invasive diagnostic tools that use high-frequency sound waves to create detailed images of the heart and its surrounding structures. These systems are essential in diagnosing, monitoring, and managing a wide range of cardiovascular conditions, including heart valve disorders, heart failure, congenital heart defects, and coronary artery disease. By generating real-time images of the heart’s chambers, valves, and blood flow, cardiovascular ultrasound systems allow physicians to evaluate the heart’s function without the need for more invasive procedures, such as catheterization or surgery. The ability to quickly assess heart health and detect abnormalities in real time has made cardiovascular ultrasound a cornerstone of modern cardiology, especially in outpatient, emergency, and perioperative settings. Since these systems use sound waves instead of radiation, they pose no risk to patients, making them suitable for a broad range of populations, including pregnant women and children. Cardiologists rely on these systems to perform various types of echocardiograms, such as transthoracic echocardiograms (TTE), transesophageal echocardiograms (TEE), and stress echocardiograms, each offering unique insights into different aspects of heart function. The non-invasive nature and diagnostic accuracy of cardiovascular ultrasound systems make them indispensable tools for both early diagnosis and long-term management of heart disease.

How Have Technological Advances Improved Cardiovascular Ultrasound Systems?

Technological advancements have dramatically transformed cardiovascular ultrasound systems, enhancing their diagnostic capabilities, portability, and ease of use. One of the most significant developments is the introduction of three-dimensional (3D) and four-dimensional (4D) echocardiography, which offers real-time, detailed images of the heart in motion. These technologies provide a more comprehensive view of the heart’s structure and function, allowing clinicians to better visualize heart valves, detect abnormalities, and plan complex interventions like valve replacements or repairs. In addition, 3D and 4D imaging can improve surgical outcomes by offering precise images of congenital heart defects or structural heart problems before the procedure even begins. This level of detail was previously unattainable with traditional two-dimensional echocardiography and has significantly improved the accuracy of diagnoses and treatment planning. Another technological leap is the rise of portable and handheld cardiovascular ultrasound systems. These compact devices enable clinicians to perform echocardiograms at a patient’s bedside, in the emergency department, or even in remote locations, without the need for large, stationary machines. This portability increases access to critical diagnostic tools, particularly in underserved or rural areas where traditional echocardiography systems may not be available. Additionally, many of the latest ultrasound systems are now equipped with advanced AI and machine learning algorithms that assist in image interpretation and analysis. These AI-enhanced systems can automatically detect and quantify heart abnormalities, significantly reducing the time required for manual analysis and improving diagnostic consistency. Cloud-based connectivity and data-sharing capabilities further enhance the functionality of modern ultrasound systems, allowing for real-time collaboration between healthcare providers and remote specialists, ensuring timely and accurate patient care.

What Are the Emerging Trends in Cardiovascular Ultrasound Systems?

Several emerging trends are driving the continued evolution of cardiovascular ultrasound systems, reflecting advancements in medical imaging technology and changing healthcare needs. One major trend is the growing use of point-of-care ultrasound (POCUS) in cardiology, which is reshaping how and where ultrasound examinations are performed. POCUS systems are small, portable devices that allow healthcare providers to perform echocardiograms at the patient’s bedside or in outpatient settings. This trend is increasing access to cardiovascular imaging, particularly in emergency settings where rapid diagnosis is critical. It is also extending the use of ultrasound into primary care and general practice, enabling early detection of cardiovascular issues without the need for specialized imaging centers. The integration of artificial intelligence (AI) and machine learning into cardiovascular ultrasound systems is another significant trend. AI is being used to automate various aspects of image acquisition, analysis, and reporting, reducing the dependency on the operator's expertise and minimizing human error. For example, AI algorithms can assist in detecting heart abnormalities, measuring ejection fraction, or tracking heart valve movements with greater precision and speed. These AI-driven features help standardize diagnostic procedures, ensuring that even less experienced operators can produce high-quality results. Another key trend is the increasing use of contrast-enhanced echocardiography, which improves the visibility of cardiac structures, particularly in patients with suboptimal image quality. Contrast agents, injected into the bloodstream, enhance the clarity of the images produced by ultrasound, enabling more accurate assessments of conditions like ischemic heart disease or myocardial infarctions. Finally, the trend toward interoperability is making it easier for cardiovascular ultrasound systems to integrate with broader hospital information systems (HIS) and cardiovascular information systems (CVIS), creating a seamless flow of patient data across different departments and improving care coordination.

What Factors Are Fueling the Expansion of the Cardiovascular Ultrasound Systems Market?

The growth in the cardiovascular ultrasound systems market is driven by several factors, primarily linked to advancements in technology, rising healthcare demands, and the evolving needs of healthcare providers. One of the most significant drivers is the increasing global prevalence of cardiovascular diseases, such as heart failure, coronary artery disease, and hypertension. As these conditions continue to rise, the demand for non-invasive, accurate, and cost-effective diagnostic tools like cardiovascular ultrasound systems has surged. Healthcare providers are increasingly relying on these systems to diagnose heart conditions early, monitor disease progression, and evaluate the effectiveness of treatments, all of which contribute to improved patient outcomes. Another major growth driver is the shift towards more portable and point-of-care ultrasound devices, which have expanded the use of echocardiography beyond traditional hospital settings. Portable devices enable healthcare providers to bring diagnostic imaging to patients, particularly in emergency situations or in remote areas, ensuring timely care and reducing the need for expensive and invasive procedures. Technological advancements, such as 3D and 4D imaging, AI integration, and cloud connectivity, have also fueled market growth by improving the functionality, accuracy, and ease of use of these systems. Furthermore, the rising adoption of AI in healthcare is enhancing the diagnostic capabilities of these systems, allowing for faster and more consistent image interpretation. The trend toward value-based care, where the focus is on improving outcomes while controlling costs, has further driven the adoption of cardiovascular ultrasound systems, as they offer a cost-effective, non-invasive alternative to other imaging modalities like CT or MRI. Lastly, growing investments in healthcare infrastructure, particularly in developing regions, are expanding access to advanced ultrasound technologies, further accelerating market growth. As healthcare systems worldwide strive to improve early diagnosis and management of cardiovascular diseases, the demand for cardiovascular ultrasound systems is expected to continue rising.

Select Competitors (Total 13 Featured) -

  • Chison Medical Imaging Co., Ltd.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Mindray Medical International Ltd.
  • Philips Healthcare
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiovascular Ultrasound Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Propels Demand for Cardiovascular Ultrasound Systems
    • Technological Advancements in 3D and 4D Imaging Strengthen the Business Case for Advanced Ultrasound Systems
    • Growing Focus on Early Detection of Heart Conditions Spurs Adoption of Cardiovascular Ultrasound Systems
    • Here's How Portable and Handheld Ultrasound Devices Are Expanding Market Opportunities in Point-of-Care Settings
    • Integration of Artificial Intelligence (AI) in Ultrasound Systems Drives Adoption of Next-Generation Cardiovascular Diagnostics
    • Increasing Demand for Non-Invasive Imaging Techniques Sustains Growth of Cardiovascular Ultrasound Systems
    • Rising Popularity of Telemedicine and Remote Diagnostics Generates Demand for Cloud-Connected Ultrasound Solutions
    • Enhanced Diagnostic Accuracy and Real-Time Imaging Propel Adoption of Cardiovascular Ultrasound Systems
    • Advancements in AI-Powered Image Analysis Generate Demand for Intelligent Cardiovascular Ultrasound Systems
    • Increasing Healthcare Infrastructure Investments in Emerging Markets Accelerate Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiovascular Ultrasound Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiovascular Ultrasound Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiovascular Ultrasound Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for 2D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for 2D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for 2D by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for 3D & 4D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for 3D & 4D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for 3D & 4D by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Doppler Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Doppler Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Doppler Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stress Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Stress Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Stress Echocardiogram by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Transthoracic Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Transthoracic Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Transthoracic Echocardiogram by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Transesophageal Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Transesophageal Echocardiogram by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Transesophageal Echocardiogram by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Black & White by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Black & White by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Black & White by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Color by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Color by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Color by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: China 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: China 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Cardiovascular Ultrasound Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: France 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: France 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: France 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular Ultrasound Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Asia-Pacific 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Cardiovascular Ultrasound Systems by Technology - 2D, 3D & 4D and Doppler Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of World 16-Year Perspective for Cardiovascular Ultrasound Systems by Technology - Percentage Breakdown of Value Sales for 2D, 3D & 4D and Doppler Imaging for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Cardiovascular Ultrasound Systems by Test Type - Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of World 16-Year Perspective for Cardiovascular Ultrasound Systems by Test Type - Percentage Breakdown of Value Sales for Stress Echocardiogram, Transthoracic Echocardiogram, Transesophageal Echocardiogram and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Cardiovascular Ultrasound Systems by End-Use - Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of World 16-Year Perspective for Cardiovascular Ultrasound Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Ambulatory Care Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Cardiovascular Ultrasound Systems by Device Display - Black & White and Color Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of World 16-Year Perspective for Cardiovascular Ultrasound Systems by Device Display - Percentage Breakdown of Value Sales for Black & White and Color for the Years 2014, 2024 & 2030

IV. COMPETITION